4.8 Article

Time Rules the Efficacy of Immune Checkpoint Inhibitors in Photodynamic Therapy

Related references

Note: Only part of the references are listed.
Review Cell Biology

Tumor-derived exosomes in the PD-1/PD-L1 axis: Significant regulators as well as promising clinical targets

Benhui Liang et al.

Summary: The binding of PD-1 to its ligand PD-L1 is crucial for maintaining the non-reactivity of T cells, while tumor cells restrict cellular immune response by highly expressing PD-L1. TEXs can carry PD-L1 and regulate the PD-1/PD-L1 axis to promote tumor progression.

JOURNAL OF CELLULAR PHYSIOLOGY (2021)

Article Immunology

Dynamic CD4(+) T cell heterogeneity defines subset-specific suppression and PD-L1-blockade-driven functional restoration in chronic infection

Laura M. Snell et al.

Summary: Inhibiting PD-1:PD-L1 signaling can restore the immune function of CD4(+) T cells in chronic infections and modulate the activation of T regulatory cells. This study demonstrates the heterogeneity of CD4(+) T cells in chronic viral infection and shows that PD-L1 blockade can enhance cytotoxic gene programs in antigen-specific T(H)1 cells.

NATURE IMMUNOLOGY (2021)

Article Chemistry, Multidisciplinary

Nanomedicines inhibiting tumor metastasis and recurrence and their clinical applications

Xiangyi Kong et al.

Summary: The use of nanoparticles in tumor treatment can effectively inhibit tumor metastasis and recurrence. Through targeting probes and chemotherapy drugs, nanoparticles can accumulate at tumor sites and inhibit the proliferation and metastasis of tumor cells, while also capturing circulating tumor cells to prevent metastasis and recurrence.

NANO TODAY (2021)

Review Immunology

Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to Therapy

Weiqin Jiang et al.

Summary: Tumor-specific CD8(+) T cells exposed to persistent antigenic stimulation undergo a dysfunctional state called exhaustion, leading to attenuated effector function and failure to control tumor progression. Research is dissecting the dynamic differentiation process during exhaustion and identifying specific biomarkers.

FRONTIERS IN IMMUNOLOGY (2021)

Article Biochemistry & Molecular Biology

CXCR6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironment

Mauro Di Pilato et al.

Summary: The conversion of stem-like CTLs into effector-like CTLs involves chemotactic reprogramming with upregulation of chemokine receptor CXCR6. CXCR6 expression and IL-15 trans-presentation are crucial for the survival and local expansion of effector-like CTLs in the tumor microenvironment.
Review Immunology

Dendritic cell migration in inflammation and immunity

Juan Liu et al.

Summary: Dendritic cells play crucial roles in immune defense and tolerance, but dysregulation of their migration can lead to immune imbalance and diseases. Researchers are exploring new strategies targeting the migration of distinct dendritic cell subsets for the treatment of related diseases.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

Review Immunology

Interaction between intestinal microbiota and tumour immunity in the tumour microenvironment

Xiuxiu Yang et al.

Summary: Studies have shown that intestinal microbiota have a significant impact on tumor immunity, with certain bacteria improving the effect of tumor immunity while microbial imbalance can lead to tumor formation and progression. Additionally, some microbiota play important roles in tumor immunotherapy.

IMMUNOLOGY (2021)

Review Biochemistry & Molecular Biology

The roles of tumor-derived exosomes in altered differentiation, maturation and function of dendritic cells

Reza Hosseini et al.

Summary: This paper delves into the impact of tumor-derived exosomes on dendritic cells and how they induce subversion of DCs differentiation, maturation, and function, as well as their significance at the therapeutic level. Understanding the exosomal content and pathways responsible for immune evasion could lead to the development of novel therapeutic approaches.

MOLECULAR CANCER (2021)

Article Immunology

Influence of Tumor Immune Infiltration on Immune Checkpoint Inhibitor Therapeutic Efficacy: A Computational Retrospective Study

Rong Liu et al.

Summary: Analyzing multiple ICI clinical trial samples revealed specific subsets of immune cells related to response and survival, laying the groundwork for achieving durable efficacy.

FRONTIERS IN IMMUNOLOGY (2021)

Review Oncology

Immune Checkpoints in Cancers: From Signaling to the Clinic

Celine Pisibon et al.

Summary: Immune checkpoint therapies have revolutionized cancer treatment by reactivating the patient's immune system. Despite clear benefits observed in patients, many still fail to respond or develop resistance to these treatments. Understanding the mechanisms of immune checkpoints is essential for overcoming resistance and improving clinical outcomes.

CANCERS (2021)

Review Chemistry, Medicinal

Physicochemical Stability of Monoclonal Antibodies: A Review

Yoann Le Basle et al.

JOURNAL OF PHARMACEUTICAL SCIENCES (2020)

Review Oncology

Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors

Lorenzo Galluzzi et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2020)

Article Multidisciplinary Sciences

Glucocorticoids promote breast cancer metastasis

Milan M. S. Obradovic et al.

NATURE (2019)

Review Chemistry, Multidisciplinary

Immunomodulatory Nanosystems

Xiangru Feng et al.

ADVANCED SCIENCE (2019)

Review Medicine, Research & Experimental

Photodynamic therapy - mechanisms, photosensitizers and combinations

Stanislaw Kwiatkowski et al.

BIOMEDICINE & PHARMACOTHERAPY (2018)

Article Biochemistry & Molecular Biology

T cell exhaustion in cancer: Mechanisms and clinical implications

Jin-Cheng Wang et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2018)

Article Chemistry, Multidisciplinary

Nanoscale Metal-Organic Framework Overcomes Hypoxia for Photodynamic Therapy Primed Cancer Immunotherapy

Guangxu Lan et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2018)

Review Multidisciplinary Sciences

Cancer immunotherapy using checkpoint blockade

Antoni Ribas et al.

SCIENCE (2018)

Article Biochemistry & Molecular Biology

Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma

Moshe Sade-Feldman et al.

Review Immunology

NF-κB, inflammation, immunity and cancer: coming of age

Koji Taniguchi et al.

NATURE REVIEWS IMMUNOLOGY (2018)

Review Multidisciplinary Sciences

Elements of cancer immunity and the cancer-immune set point

Daniel S. Chen et al.

NATURE (2017)

Editorial Material Oncology

Tumour microenvironment: informing on minimal residual disease in solid tumours

Klaus Pantel et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2017)

Review Oncology

Immune Checkpoint Blockade in Cancer Therapy

Michael A. Postow et al.

JOURNAL OF CLINICAL ONCOLOGY (2015)

Editorial Material Allergy

Optimal duration of allergen immunotherapy

Efren Rael et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)

Review Immunology

T cell exhaustion

E. John Wherry

NATURE IMMUNOLOGY (2011)

Review Biochemistry & Molecular Biology

The space and time frames of T cell activation at the immunological synapse

Salvatore Valitutti et al.

FEBS LETTERS (2010)

Review Oncology

Photodynamic therapy and anti-tumour immunity

Ana P. Castano et al.

NATURE REVIEWS CANCER (2006)